Pacific Biosciences of California Inc expected to post a loss of 23 cents a share - Earnings Preview

Pacific Biosciences of California

06/08/2024 03:08

* Pacific Biosciences of California Inc  PACB.OQ 
 PACB.O  is
expected to show a fall in quarterly revenue when it reports 
results on August 7 for the period ending June 30 2024
    * The Menlo Park California-based  company is expected to
report a
14.1% decrease in revenue to $40.878 million from $47.57 million
a year ago, according to the mean estimate from 12 analysts,
based on LSEG data.
    * ​LSEG's mean analyst estimate for Pacific Biosciences of
California Inc is for a loss of 23 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 7 "strong buy" or "buy," 8
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Pacific
Biosciences of California Inc is $3.00​, above​ its last closing
price of $1.55. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Mar. 31 2024  -0.28       -0.28      -0.29     Missed  -5.3
 Dec. 31 2024  -0.29       -0.29      -0.31     Missed  -8.7
 Sep. 30 2023  -0.34       -0.33      -0.26     Beat    20.8​
 Jun. 30 2023  -0.32       -0.32      -0.28     Beat    12.7
 ​​Mar.        -0.33       -0.33      -0.36     Missed  -8.3
 31 2023                                                
 Dec. 31 2022  -0.37       -0.36      -0.37     Missed  -2.4​
 Sep. 30 2022  -0.33       -0.33      -0.34     Missed  -2.5
 Jan. 1 0001   -0.32       -0.32      -0.32     Met     1
 This summary was machine generated August 6 at 02:08 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)